These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7007398)

  • 1. Insulin inhibition of protein degradation in cell monolayers.
    Ballard FJ; Wong SS; Knowles SE; Partridge NC; Martin TJ; Wood CM; Gunn JM
    J Cell Physiol; 1980 Nov; 105(2):335-46. PubMed ID: 7007398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between insulin binding and the inhibition of protein degradation in normal and transformed cells.
    Ballard FJ; Gunn JM
    Horm Metab Res; 1980 Jan; 12(1):10-4. PubMed ID: 6987137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between the insulin content and inhibitory effects of bovine colostrum on protein breakdown in cultured cells.
    Ballard FJ; Nield MK; Francis GL; Dahlenburg GW; Wallace JC
    J Cell Physiol; 1982 Mar; 110(3):249-54. PubMed ID: 7045139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extent of mitogen receptor occupancy and modulation of mitogen receptor exposure: possible mechanisms for the regulation of cell growth.
    Perdue JF; Raizada MK
    Prog Clin Biol Res; 1976; 9():49-64. PubMed ID: 193133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the inhibition of protein degradation by insulin in L6 cells.
    Fawcett J; Hamel FG; Duckworth WC
    Arch Biochem Biophys; 2001 Jan; 385(2):357-63. PubMed ID: 11368017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of intracellular protein degradation by insulin and growth factors.
    Ballard FJ; Nield MK; Francis GL; Knowles SE
    Acta Biol Med Ger; 1981; 40(10-11):1293-300. PubMed ID: 6282020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein degradation in 3T3 cells and tumorigenic transformed 3T3 cells.
    Gronostajski RM; Pardee AB
    J Cell Physiol; 1984 Apr; 119(1):127-32. PubMed ID: 6323489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced insulin endocytosis in serum-transformed fibroblasts demonstrated by flow cytometry.
    Murphy RF; Powers S; Cantor CR; Pollack R
    Cytometry; 1984 May; 5(3):275-80. PubMed ID: 6376000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of serum and conditioned medium on protein degradation, migration of nonhistone proteins to the nucleus, and DNA synthesis in transformed cells.
    Polet H; Swager JS
    J Cell Physiol; 1987 Mar; 130(3):436-43. PubMed ID: 3558494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular protein degradation in growing, in density-inhibited, and in serum-restricted fibroblast cultures.
    Hendil KB
    J Cell Physiol; 1977 Sep; 92(3):353-64. PubMed ID: 198415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor (IGF) I down-regulates type 1 IGF receptor (IGF 1R) and reduces the IGF I response in A549 non-small-cell lung cancer and Saos-2/B-10 osteoblastic osteosarcoma cells.
    Bostedt KT; Schmid C; Ghirlanda-Keller C; Olie R; Winterhalter KH; Zapf J
    Exp Cell Res; 2001 Dec; 271(2):368-77. PubMed ID: 11716549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of nelfinavir on insulin metabolism, proteasome activity and protein degradation in HepG2 cells.
    Hamel FG; Fawcett J; Tsui BT; Bennett RG; Duckworth WC
    Diabetes Obes Metab; 2006 Nov; 8(6):661-8. PubMed ID: 17026490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble insulin-like growth factor II/mannose 6-phosphate receptor inhibits DNA synthesis in insulin-like growth factor II sensitive cells.
    Scott CD; Weiss J
    J Cell Physiol; 2000 Jan; 182(1):62-8. PubMed ID: 10567917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional insulin and insulin-like growth factor-1 receptors are preferentially expressed in multiple myeloma cell lines as compared to B-lymphoblastoid cell lines.
    Freund GG; Kulas DT; Way BA; Mooney RA
    Cancer Res; 1994 Jun; 54(12):3179-85. PubMed ID: 8205537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth factor-like properties of parathyroid hormone-related peptide in transfected rodent cell line.
    Li X; Drucker DJ
    Cancer Res; 1993 Jul; 53(13):2980-6. PubMed ID: 8319205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone-defined cell system for studying G-protein coupled receptor agonist-activated growth modulation: delta-opioid and serotonin-5HT2C receptor activation show opposite mitogenic effects.
    Agarwal D; Glasel JA
    J Cell Physiol; 1997 Apr; 171(1):61-74. PubMed ID: 9119893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human insulin-like growth factor (IGF) binding protein-3 stimulates prostate carcinoma cell proliferation via an IGF-dependent mechanism. Role of serine proteases.
    Angelloz-Nicoud P; Harel L; Binoux M
    Growth Regul; 1996 Sep; 6(3):130-6. PubMed ID: 8894645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
    Choe C; Chen N; Sawadogo M
    Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in anchorage-dependent growth and tumorigenicities between transformed C3H/10T 1/2 cells with morphologies that are or are not reverted to a normal phenotype by ascorbic acid.
    Benedict WF; Wheatley WL; Jones PA
    Cancer Res; 1982 Mar; 42(3):1041-5. PubMed ID: 7059969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The cultivation features, growth characteristics and oncogenicity of "serum-free" populations of transformed fibroblasts].
    Pleskach VA; Kozhukharova IV; Artsybasheva IV; Goĭlo TA; Tarunina MV; Filatova NA
    Tsitologiia; 1994; 36(8):806-15. PubMed ID: 7701611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.